Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Advance of molecular subtyping and precise treatment for gliomas].

Zhonghua wai ke za zhi [Chinese journal of surgery] - 1 Jan 2017

Hua W, Mao Y

Abstract excerpt

With the advance of genomics research, there have been a new breakthrough in the molecular classification of gliomas. Glioblastoma (WHO grade Ⅳ) could be subtyped to proneural, neural, classical, and mesochymal according to the mRNA expression. Lower grade gliomas (WHO grade Ⅱ and Ⅲ) could be divided into 5 types using 1p/19q co-deletion, isocitrate dehydrogenase(IDH) mutation, and TERTp (promotor region)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosome Deletion
Share to Chromosomes, Human, Pair 1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genomics

Share to Glioblastoma

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Precision Medicine

Source

Identifiers

PMID: 28056258
DOI: 10.3760/cma.j.issn.0529-5815.2017.01.016

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Advance of molecular subtyping and precise treatment for gliomas].PMID 28056258Read ↗

[Basic principles of diagnosis and treatment of gliomas].Semantic proximity Read ↗

[Lower-grade Gliomas].Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

[Precision Medicine for IDH-mutant Diffuse Glioma(Lower-grade Glioma)].Semantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Semantic proximity Read ↗

Glioma.Semantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese CenterSemantic proximity Read ↗

Clinical implications of molecular analysis in diffuse glioma stratification.Semantic proximity Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

[How molecular biology can improve the clinical diagnosis of gliomas?]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.